(Q42283638)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Novel retrovirus protease inhibitors, RPI-856 A, B, C and D, produced by Streptomyces sp. AL-322 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

Streptomyces graminofaciens

23 October 2019

main subject

1 reference

1 reference

Streptomyces hygroscopicus

1 reference

Streptomyces halstedii

1 reference

Valyl-[2(R or S)-amino-2-(3,5-dihydroxyphenyl)acetic acid]-leucyl-[3(S)-amino-2-oxo-4-phenylbutyric acid]-valyl-valyl-aspartic acid, diastereomer of RPI-856B

1 reference

(3E,5E,7R,8R,9E,13E,16S)-8-hydroxy-3,5,7-trimethyl-16-[(E,2S,7S,8R,9S,10R,11S)-7,9,11-trihydroxy-8,10-dimethyldodec-4-en-2-yl]-1-oxacyclohexadeca-3,5,9,13-tetraen-2-one

1 reference

(1S,2S,3R,4Z,6Z,10S,12Z,14Z)-10-[(5S,6R,7R,8S,9S)-5,7-Dihydroxy-9-methoxy-6,8-dimethyldecan-2-YL]-2,17-dihydroxy-3,5,7-trimethyl-9,19-dioxabicyclo[16.1.0]nonadeca-4,6,12,14-tetraen-8-one

1 reference

(1S,2R,4E,7S,10E,12E,14R,15S,16S)-7-[(E,2S,7S,8R,9R,10S,11S)-7,9-dihydroxy-11-methoxy-8,10-dimethyldodec-4-en-2-yl]-2,15-dihydroxy-10,12,14-trimethyl-8,17-dioxabicyclo[14.1.0]heptadeca-4,10,12-trien-9-one

1 reference

[(2R,3R,4E,6S,7R,10R)-7,10-dihydroxy-2-[(2Z,4E,6S,7S)-7-hydroxy-7-[(2R,3R)-3-[(2R,3R)-3-methoxypentan-2-yl]oxiran-2-yl]-6-methylhepta-2,4-dien-2-yl]-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] acetate

1 reference

1 reference

(2R,4S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-2-(3,5-dihydroxyphenyl)acetyl]amino]-4-methylpentanoyl]-[(2S)-2-[(3-amino-2-oxo-4-phenylbutanoyl)amino]-3-methylbutanoyl]amino]-5-methyl-3-oxo-2-propan-2-ylhexanoic acid

1 reference

Valyl-[2(R or S)-amino-2-(3,5-dihydroxyphenyl)acetic acid]-leucyl-[3(R)-amino-2-oxo-4-phenylbutyric acid]-valyl-valyl-aspartic acid, diastereomer of RPI-856A

1 reference

T Asano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

K Matsuoka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

T Hida

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M Kobayashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Y Kitamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

T Hayakawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

S Iinuma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A Kakinuma

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

K Kato

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1994

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/47/5/47_5_557/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.47.557?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

557-565

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.47.557?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

THE ESTIMATION OF PEPSIN, TRYPSIN, PAPAIN, AND CATHEPSIN WITH HEMOGLOBIN.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

A high throughput assay for inhibitors of HIV-1 protease. Screening of microbial metabolites

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Rational design of peptide-based HIV proteinase inhibitors

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Poststatin, a new inhibitor of prolyl endopeptidase, produced by Streptomyces viridochromogenes MH534-30F3. II. Structure determination and inhibitory activities.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.956

L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Taxonomic status of Kitasatosporia, and proposed unification with Streptomyces on the basis of phenotypic and 16S rRNA analysis and emendation of Streptomyces Waksman and Henrici 1943, 339AL.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

The structure of bestatin

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.29.100

Kitasatosporia, a new genus of the order Actinomycetales.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.47.557

Identifiers

DOI

10.7164/ANTIBIOTICS.47.557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8040053%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference